SCHEMBL6417309

SCHEMBL6417309

COCCNC(=O)C1c2ccccc2C(=O)N(C(C)C)C1c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
MAPT P10636 4/20 0.55
HTT P42858 4/20 0.55
KDM4E B2RXH2 2/20 0.55
TP53 P04637 2/20 0.52
MDM2 Q00987 1/20 0.52
TSHR P16473 2/20 0.47
NPSR1 Q6W5P4 6/20 0.46
GAA P10253 1/20 0.46
GLA P06280 1/20 0.43
CASP1 P29466 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
LMNA P02545 2/20 0.41
HSD17B10 Q99714 1/20 0.40
ALOX15 P16050 1/20 0.40
BRS3 P32247 1/20 0.39
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6413224 0.88 ALDH1A1 (0.60) ALDH1A1MAPTHTTKDM4ETP53
SCHEMBL6412385 0.86 ALDH1A1 (0.74) ALDH1A1MAPTHTTKDM4ETP53
SCHEMBL6414939 0.86 ALDH1A1 (0.74) ALDH1A1MAPTHTTKDM4ETP53
SCHEMBL2939041 0.85 ALDH1A1 (0.54) ALDH1A1MAPTHTTKDM4ETP53
SCHEMBL6417311 0.85 ALDH1A1 (0.66) ALDH1A1MAPTHTTKDM4ETP53
SCHEMBL6411391 0.83 ALDH1A1 (0.45) ALDH1A1MAPTHTTKDM4ETP53
SCHEMBL6410223 0.82 ALDH1A1 (0.42) ALDH1A1MAPTHTTKDM4ETP53
SCHEMBL6418274 0.82 MAPK1 (0.51) ALDH1A1MAPTHTTKDM4ETSHR
SCHEMBL6418778 0.81 ALDH1A1 (0.61) ALDH1A1MAPTHTTKDM4ETP53
SCHEMBL6411589 0.81 MDM2 (0.68) ALDH1A1MAPTHTTKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US claimed
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US disclosed
WO-2004004727-A1 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS AXYS PHARMACEUTICALS, INC. (US) 2004-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis CASP3, BAX, BAD ALDH1A1 1368/4885MAPT 3291/4885HTT 3051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.